UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression

Clinical pharmacokinetics, 2000-12, Vol.39 (6), p.413-427

FLEISHAKER, Joseph C

2000

Volltextzugriff (PDF)

Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice

Clinical pharmacology and therapeutics, 2010-03, Vol.87 (3), p.278-285

2010

Volltextzugriff (PDF)

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

European journal of clinical pharmacology, 1994-02, Vol.46 (1), p.35-39

1994

Volltextzugriff (PDF)

Evaluation of the Potential Pharmacokinetic Interaction between Almotriptan and Fluoxetine in Healthy Volunteers

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.217-223

2001

Volltextzugriff (PDF)

Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans

Clinical pharmacology and therapeutics, 1999-10, Vol.66 (4), p.374-379

1999

Volltextzugriff (PDF)

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

Psychopharmacologia, 1991-09, Vol.104 (3), p.323-327

1991

Volltextzugriff (PDF)

A Comparison of the Pharmacokinetics and Tolerability of the Anti-Migraine Compound Almotriptan in Healthy Adolescents and Adults

Cephalalgia, 2004-04, Vol.24 (4), p.288-292

2004

Volltextzugriff (PDF)

Alprazolam absorption kinetics affects abuse liability

Clinical pharmacology and therapeutics, 1995-03, Vol.57 (3), p.356-365

1995

Volltextzugriff (PDF)

Pharmacokinetics of reboxetine in elderly patients with depressive disorders

International journal of clinical pharmacology and therapeutics, 2000-05, Vol.38 (5), p.254-259

2000

Volltextzugriff (PDF)

Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N-Desmethyladinazolam in Man

Journal of pharmacy and pharmacology, 1998-03, Vol.50 (3), p.265-274

1998

Volltextzugriff (PDF)

Pharmacokinetics of Single-Dose Reboxetine in Volunteers with Renal Insufficiency

Journal of clinical pharmacology, 2000-05, Vol.40 (5), p.482-487

2000

Volltextzugriff (PDF)

Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents

Psychopharmacologia, 2001-05, Vol.155 (2), p.148-153

2001

Volltextzugriff (PDF)

Phenytoin Causes a Rapid Increase in 6β‐Hydroxycortisol Urinary Excretion in Humans—A Putative Measure of CYP3A Induction

Journal of pharmaceutical sciences, 1995-03, Vol.84 (3), p.292-294

1995

Volltextzugriff (PDF)

Effect of age and gender on tirilazad pharmacokinetics in humans

Clinical pharmacology and therapeutics, 1994-04, Vol.55 (4), p.378-384

1994

Volltextzugriff (PDF)

Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics

Biopharmaceutics & drug disposition, 1999-01, Vol.20 (1), p.53-57

1999

Volltextzugriff (PDF)

Population pharmacokinetics of tirilazad : Effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage

Pharmaceutical research, 1999-04, Vol.16 (4), p.575-583

1999

Volltextzugriff (PDF)

Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21-Aminosteroid Free Radical Scavenger: I. Single-Dose Administration

Journal of clinical pharmacology, 1993-02, Vol.33 (2), p.175-181

1993

Volltextzugriff (PDF)

Gender does not affect the degree of induction of tirilazad clearance by phenobarbital

European journal of clinical pharmacology, 1996, Vol.50 (1-2), p.139-145

1996

Volltextzugriff (PDF)

Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability

The Journal of pharmacology and experimental therapeutics, 1996-05, Vol.277 (2), p.991

1996

Volltextzugriff (PDF)

Hormonal Effects on Tirilazad Clearance in Women: Assessment of the Role of CYP3A

Journal of clinical pharmacology, 1999-03, Vol.39 (3), p.260-267

1999

Volltextzugriff (PDF)

Effect of MAO‐A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

British journal of clinical pharmacology, 2001-05, Vol.51 (5), p.437-441

2001

Volltextzugriff (PDF)

Pharmacokinetics of reboxetine in healthy, elderly volunteers

European journal of drug metabolism and pharmacokinetics, 2000-07, Vol.25 (3-4), p.195-198

2000

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of adinazolam : multi-ethnic comparisons

Psychopharmacologia, 1997-09, Vol.129 (3), p.265-270

1997

Volltextzugriff (PDF)

Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects

Psychopharmacologia, 1995-07, Vol.120 (2), p.169-176

1995

Volltextzugriff (PDF)

Electrocardiographic Identification of Drug-Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Annals of noninvasive electrocardiology, 2004-01, Vol.9 (1), p.48-57

2004

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(105)
Buchkapitel
(1)

Sprache

Englisch
(106)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression

Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

Evaluation of the Potential Pharmacokinetic Interaction between Almotriptan and Fluoxetine in Healthy Volunteers

Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

A Comparison of the Pharmacokinetics and Tolerability of the Anti-Migraine Compound Almotriptan in Healthy Adolescents and Adults

Alprazolam absorption kinetics affects abuse liability

Pharmacokinetics of reboxetine in elderly patients with depressive disorders

Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N-Desmethyladinazolam in Man

Pharmacokinetics of Single-Dose Reboxetine in Volunteers with Renal Insufficiency

Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents

Phenytoin Causes a Rapid Increase in 6β‐Hydroxycortisol Urinary Excretion in Humans—A Putative Measure of CYP3A Induction

Effect of age and gender on tirilazad pharmacokinetics in humans

Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics

Population pharmacokinetics of tirilazad : Effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage

Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21-Aminosteroid Free Radical Scavenger: I. Single-Dose Administration

Gender does not affect the degree of induction of tirilazad clearance by phenobarbital

Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability

Hormonal Effects on Tirilazad Clearance in Women: Assessment of the Role of CYP3A

Effect of MAO‐A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

Pharmacokinetics of reboxetine in healthy, elderly volunteers

The pharmacokinetics and pharmacodynamics of adinazolam : multi-ethnic comparisons

Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects

Electrocardiographic Identification of Drug-Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Suchergebnisse filtern